 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | Management Sciences for Health (MSH) |
| Street 1: | 4301 North Fairfax Drive |
| Street 2: | Suite 400 |
| City: | Arlington |
| Province: | Virginia |
| Post Code: | 22203 |
| Country: | United States of America |
| Phone: | 703-310-3400 |
| Organization Email: | MSH@msh.org |
| Web Site: | http://www.msh.org |
| Other Online Presence: | |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | Developed Country NGO |
| Is your organization legally registered in your country: | Yes |
| If yes, please enter your registration number: | |
| Organization Type - Primary: | Non-Governmental Organization |
| Organization Type - Secondary: | Other Non-Governmental Organization (NGO) |
| Organization Description: | |
| Management Sciences for Health (MSH) is a nonprofit international health organization composed of nearly 1,300 people from more than 60 nations. Our mission is to save lives and improve the health of the world’s poorest and most vulnerable people by closing the gap between knowledge and action in public health. Together with our partners, we are helping managers and leaders in developing countries to create stronger management systems that improve health services for the greatest health impact. | |
| Do you know about the UNHLM declaration: | |
Specializations / Areas of Work | |
|
Advocacy Delivery of health services and care Funding, including innovative and optimized approach to funding TB Care Research and Development Technical Assistance |
Other Organization Information | |
| Total number of staff in your organization: | 100 + |
| Number of full-time staff who are directly involved with TB: | 100 + |
| Number of part-time staff who are directly involved with TB: | 100 + |
| Number of volunteers who are directly involved with TB: | 0 |
| How did you hear about the Stop TB Partnership: | Involvement in TB control provision |
| If you were informed or referred by another partner of the Stop TB Partnership please tell us who: | |
| Why do you wish join the Stop TB Partnership: | Technical assistance and advice |
| Are you a member of a Stop TB national partnership: | No |
| Are you in contact with your national TB programme: | Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| MSH works with MOHs and NTPs national TB control programs to improve country ownership for TB control, strengthen monitoring and evaluation, including improving data management, implementing electronic recording and reporting systems and developing capacity to analyze and use program data for decision-making. MSH builds management systems to improve quality tuberculosis (TB) detection, diagnosis, and treatment. MSH works with national TB programs to mobilize communities to prevent and control TB and reduce stigma and discrimination. MSH promotes collaboration between TB and HIV & AIDS programs, strengthens laboratory systems, services, and networks, and works with partners to develop laboratory policies, strategies, and procedures. MSH improves management of human resources and anti-TB drug management. MSH provides technical assistance at national, regional, and local levels; capacity-building and training for TB programs and staff; tools and resources to facilitate program management and implementation; and operations research to improve TB program performance. MSH works closely with national TB control programs to strengthen monitoring and evaluation, including improving data management, implementing electronic recording and reporting systems, and developing capacity to analyze and use program data for decision-making. MSH contributes to numerous initiatives to strengthen the response to TB and HIV co-infection of children in resource-poor countries through technical assistance, health systems strengthening, and developing management and leadership capacity in the public and private sectors. |
|
Geographical Reach | |
| Which country is your headquarters located in: | United States of America |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
Afghanistan Bangladesh Cambodia Democratic Republic of the Congo Dominican Republic Ethiopia Haiti Indonesia Kenya Myanmar Peru Philippines Rwanda South Africa South Sudan Uganda Ukraine United Republic of Tanzania Viet Nam Zambia |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
TB Care Delivery: MSH has demonstrated the capacity to strengthen and expand quality DOTS programs in 15 countries. In Ethiopia, training, supportive supervision,and improved lab capacity have substantially increased the CDR in the MSH/TB CAP project areas.With the assistance of the MSH-led Rural Expansion of Afghanistan’s Community-based Healthcare (REACH) Program and other partners, the Afghan NTP expanded the number of patients receiving DOTS by 136% in four years, with an 86% treatment success rate. In Afghanistan MSH has been working leading TBCAP and TBCARE I projects improving community-based TB case detection; Urban DOTS program and capacity building of the NTP. MSH has developed and refined processes and tools that include MOST for TB to strengthen TB leadership, management, and political commitment. In addition, through its focus on leadership, organizational and financial management, supply management,and M&E, GMS enables Country Coordinating Mechanisms and Principal Recipients to address bottlenecks and accelerate performance. Since 2007, GMS has provided technical assistance to 237 Global Fund grants worth $3.07 billion in 58 countries. Through SIAPS and SCMS, MSH provides global technical leadership to increase access to and appropriate use of TB medicines and technical assistance to strengthen pharmaceutical management in support of NTPs. Drug-Resistant TB: MSH has been implemented the e- TB manager in several countries as follow: Brazil, Indonesia, Nigeria, Cambodia, Vietnam. TB-HIV: In Ethiopia: TB/HIV performance has improved in the areas supported by MSH/TB CAP, due to training and mentoring of health professionals and stronger linkages of patients to services. In 2009-10, the number of HIV-positive patients screened for TB rose from 2,934 to 4,118 in Oromia, where most of the TB CAP-supported zones are found. At the same time, HCSP screened 124,382 HIV-positive patients. Of those patients, 17,316 underwent AFB examination, 5,154 began TB treatment, 2,879 were referred to TB services, and 19,277 began IPT. Laboratory Strengthening: MSH strengthens the leadership, management, and technical skills needed by countries stakeholders to: drive development; implement policies; integrate services to meet MDR-TB and TB/HIV diagnostic needs; improve IC; and build laboratory supply-chain management and laboratory M&E and information systems. MSH has provided technical assistance in TB and HIV lab strengthening through TB CAP and TB CARE I in Ethiopia, Ghana, Malawi,Mozambique, Southern Sudan, Vietnam, Zambia and Tanzania; and through other TB initiatives in nine countries. |
|
Declaration | |
| Declaration of interests: No conflicts of interest were delacred. | |
| Application date: | September 1, 2009 |
| Last updated: | January 14, 2014 |